Related Experiment Video

Updated: Apr 5, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer

Fei Han1, Jinxi He2, Feng Li3

  • 1Human Stem Cell Institute of the General Hospital, Ningxia Medical University, Yinchuan, Ningxia 750004, China.

Biomed Research International
|August 15, 2015
PubMed

Insights

MicroRNAs (miRNAs) are emerging as key regulators in lung cancer drug resistance. Understanding their role in epidermal growth factor receptor (EGFR) signaling can improve anti-EGFR therapies and identify new biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a major global cause of cancer mortality.
  • Epidermal growth factor receptor (EGFR) signaling is crucial in lung tumorigenesis and frequently dysregulated.
  • Targeted therapies inhibiting EGFR show promise but often face drug resistance, limiting efficacy.

Purpose of the Study:

  • To summarize the role of microRNAs (miRNAs) in modulating EGFR signaling in lung cancer.
  • To review how miRNAs influence resistance to anti-EGFR therapies.
  • To highlight miRNAs as potential biomarkers and therapeutic targets for overcoming drug resistance.

Main Methods:

  • Literature review and synthesis of existing research on miRNAs, EGFR signaling, and drug resistance in lung cancer.
  • Analysis of studies correlating miRNA expression with response to anti-EGFR agents.
  • Examination of evidence for miRNAs as predictive biomarkers and therapeutic targets.

Main Results:

  • Increasing evidence links specific miRNAs to drug resistance in lung cancer cells treated with anti-EGFR agents.
  • miRNAs are identified as regulators of EGFR signaling pathways.
  • These miRNAs show potential as predictive biomarkers for anti-EGFR therapy response.

Conclusions:

  • MicroRNAs play a significant role in regulating EGFR signaling and mediating resistance to anti-EGFR therapies in lung cancer.
  • miRNAs represent promising biomarkers for predicting patient response to EGFR inhibitors.
  • Targeting miRNAs could offer novel strategies to overcome drug resistance and improve lung cancer treatment outcomes.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

512
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K